Directory Category: Drug Discovery
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
15 December 2025 — Geneva, Switzerland — MindMaze Therapeutics Holding SA announced today the completion of its business combination with NeuroX Group SA (NeuroX), a commercial-stage company delivering...
Read More
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS Platform Trial Next steps include obtaining...
Read MoreProteoNic 2G UNic Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies
11 December 2025 — Leiden, The Netherlands — ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic® technology...
Read More